Evidence map›Paper›PMID 26139146›Full record

ArticleScientific reports2015

TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese.

Fengjiang Wei, Chunyou Cai, Shuzhi Feng, Jia Lv, Shen Li, Baocheng Chang, Hong Zhang, Wentao Shi, Hongling Han, Chao Ling and 19 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Cellular senescence: Implications for metabolic disease.Molecular and cellular endocrinology · 2017
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 1 country.

Fengjiang WeiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Chunyou CaiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Shuzhi FengTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Jia LvResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Shen LiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Baocheng ChangMetabolic Diseases Hospital, Tianjin Medical University, Tianjin, 300070, China.
Hong ZhangEye Hospital, Tianjin Medical University, Tianjin, 300384, China.
Wentao ShiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Hongling HanTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Chao LingResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Ping YuResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Yongjun ChenEye Hospital, Tianjin Medical University, Tianjin, 300384, China.
Ning SunTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Jianli TianTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Hongxiao JiaoResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Fuhua YangResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Mingshan LiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Yuhua WangResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Lei ZouResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Long SuEye Hospital, Tianjin Medical University, Tianjin, 300384, China.
Jingbo LiTianjin People's Hospital, Department of Endocrinology, Tianjin, 300191, China.
Ran LiTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Huina QiuTianjin People's Hospital, Department of Endocrinology, Tianjin, 300191, China.
Jingmin ShiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Shiying LiuTianjin General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Mingqin ChangResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Jingna LinTianjin People's Hospital, Department of Endocrinology, Tianjin, 300191, China.
Liming ChenMetabolic Diseases Hospital, Tianjin Medical University, Tianjin, 300070, China.
Wei-Dong LiResearch Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Tianjin Medical University · CNTianjin Medical University General Hospital · CNTianjin People's Hospital · CNTianjin Infectious Diseases Hospital · CNTianjin Medical University Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study associations between type 2 diabetes (T2DM) candidate genes and microvascular complications of diabetes (MVCDs), we performed case-control association studies for both T2DM and MVCDs in Han Chinese subjects. We recruited 1,939 unrelated Han Chinese T2DM patients and 918 individuals with normal blood glucose levels as nondiabetic controls. Among T2DM patients, 1116 have MVCDs, 266 have a history of T2DM of >10 years but never developed MVCDs. Eighty-two single-nucleotide polymorphisms (SNPs) in 54 candidate genes were genotyped. Discrete association studies were performed by the PLINK program for T2DM and MVCDs. Significant associations were found among candidate gene SNPs and T2DM, including rs1526167 of the TOX gene (allele A, P = 2.85 × 10(-9), OR = 1.44). The SNP rs10811661 of the CDKN2A/B gene was also associated with T2DM (allele T, P = 4.09 × 10(-7), OR = 1.36). When we used control patients with >10 years of T2DM history without MVCD, we found that the G allele of SNP rs1526167 of the TOX gene was associated with MVCD (nominal P = 4.33 × 10(-4)). In our study, significant associations were found between TOX and CDKN2A/B gene SNPs and T2DM. The TOX polymorphism might account for the higher risk of T2DM and the lower risk of MVCDs in the Han Chinese population.

Indexed as

AgedAsian PeopleCase-Control StudiesCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16Diabetes Mellitus, Type 2Diabetic AngiopathiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHigh Mobility Group ProteinsHumansMaleMiddle AgedPolymorphism, Single NucleotideCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16High Mobility Group ProteinsTOX protein, human

Identifiers

PMID26139146
PMCPMC4650661
OpenAlexW2258978467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.